TURMETABART ADIZUTECAN
UNII U9G63L4FA6

Substance Identification & Data

This profile provides standardized clinical and technical data for Turmetabart Adizutecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U9G63L4FA6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3034205-72-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
U9G63L4FA6
CAS Registry Number
3034205-72-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TURMETABART ADIZUTECAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C198215
National Cancer Institute reference terminology for clinical and research data.
INN ID
13671
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Turmetabart Adizutecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TURMETABART ADIZUTECAN

Common Names & Synonyms

IMMUNOGLOBULIN G1 (218-SERINE,DE-445-LYSINE), ANTI-(HUMAN SEIZURE PROTEIN 6 HOMOLOG) (HUMAN-MUS MUSCULUS MONOCLONAL PR-1744211 .GAMMA.1-CHAIN), COMPLEX WITH HUMAN-MUS MUSCULUS MONOCLONAL PR-1744211 .KAPPA.-CHAIN, DIMER, 218'',218''',224,224',227,227'-HEXAKIS(THIOETHER) WITH N-(2-MERCAPTOACETYL)-L-VALYL-N-(3-((7S)-7-ETHYL-7,8,11,13-TETRAHYDRO-7-HYDROXY-8,11-DIOXO-10H-1,3-DIOXOLO(4,5-G)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-14-YL)BICYCLO(1.1.1)PENT-1-YL)-L-ALANINAMIDE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS SEZ6 (SEIZURE RELATED 6 HOMOLOG)), HUMANIZED MONOCLONAL ANTIBODY, CONJUGATED ON SIX CYSTEINYL RESIDUES TO ADIZUTECAN, COMPRISING A LINKER AND A CAMPTOTHECIN DERIVATIVE (TURMETABART ADIZUTECAN)
TURMETABART ADIZUTECAN [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus